Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPD

Clinical trial NCT00263874 · TERMINATED

Trial details

NCT number: NCT00263874
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2005-11-01
Enrollment: 324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.